Related Experiment Videos
Insulin-binding antibodies in relation to insulin therapy
Journal of Clinical Pathology
|March 1, 1963
Summary
Researchers detected insulin-binding antibodies in patients using radioactively labeled insulin. These antibodies, found mainly in those needing high insulin doses, are linked to beta and gamma globulins.
Area of Science:
- Immunology
- Endocrinology
- Biochemistry
Background:
- Insulin therapy is common for managing diabetes.
- Antibody formation can complicate insulin treatment.
- Understanding these antibodies is crucial for patient care.
Purpose of the Study:
- To describe methods for detecting insulin-binding or transporting antibodies.
- To investigate the prevalence of these antibodies in insulin-treated patients.
Main Methods:
- Utilized radioactively labeled insulin (insulin (131)I) for detection.
- Analyzed protein fractions (beta and gamma globulins) associated with antibodies.
Main Results:
- Detected insulin-binding antibodies in a high proportion of patients.
- Antibody prevalence was higher in patients requiring large insulin doses.
- Identified beta and gamma globulins as the concerned protein fractions.
Conclusions:
- Insulin-binding antibodies are a significant phenomenon in insulin therapy.
- The presence of these antibodies may impact treatment efficacy.
- Further discussion on the clinical significance is warranted.
Keywords:
INSULIN ANTIBODIES